NYU Innovation Venture Fund portfolio company, Opentrons (cofounded by Will Canine, Tisch ITP '15) produces robotic lab automation workstations that are currently being used for COVID-19 testing. Opentrons' workstations plate samples, perform the RNA extraction, and execute the RT-qPCR preparation. Working with CDC-affiliate labs and hospitals around the world, their systems can deliver 10x the testing throughput of current facilities running COVID-19 testing, enabling them to immediately scale up to automated operations. Their workstations are going through the process for Emergency Use Authorization by the FDA.
